Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4Carcinoma, Hepatocellular 3Ovarian Neoplasms 2Neoplasms 2Fallopian Tube Neoplasms 2Stomach Neoplasms 1Stereotactic Body Radiation Therapy 1Radiation Pneumonitis 1Brain Neoplasms 1Advanced Non-squamous Non-small Cell Lung Cancer 1Adenocarcinoma of Lung 1

Interventions

nintedanib 2durvalumab 2Radiotherapy 2Immunotherapy 2tislelizumab 1sugemalimab 1sintilimab 1pembrolizumab 1camrelizumab 1beclomethasone 17-monopropionate 1aumolertinib 1atezolizumab 1apatinib 1Tomography, Emission-Computed, Single-Photon 1Surveys and Questionnaires 1Respiratory Function Tests 1Prednisone 1Nivolumab 1Nicorandil 1Immunoglobulin G 1Immune Checkpoint Inhibitors 1Hyperbaric Oxygenation 1Exercise Test 1Esophagectomy 1Enalapril 1Disulfides 1Dexamethasone 1Cisplatin 1Breath Holding 1Angiogenesis Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Radiation Pneumonitis × Angiogenesis Inhibitors × Clear all
NCT06700421 2024-11-22

Phase II Clinical Study of Adebrelimab Combined with Apatinib in the Treatment of Locally Advanced Non-small Cell Lung Cancer Patients with Radiation Pneumonitis

Chongqing University Cancer Hospital

Phase 2 Active not recruiting
32 enrolled

Radiation Pneumonitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡